Laurion Capital Management LP Eli Lilly & CO Put Options Transaction History

Laurion Capital Management LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $21.2 Million - $26.3 Million	-94,200 Reduced 51.06%	90,300 $24.9 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $40.9 Million - $50.3 Million	184,500 New	184,500 $42.6 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.56 Million - $1.87 Million	-11,400 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $1.36 Million - $1.68 Million	11,400 New	11,400 $1.58 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $8.02 Million - $9.93 Million	-75,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $8.01 Million - $8.71 Million	75,000 New	75,000 $8.39 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $13.9 Million - $16.4 Million	-125,100 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $8.25 Million - $9.24 Million	-77,900 Reduced 38.37%	125,100 $14.5 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $9.7 Million - $12.1 Million	113,000 Added 125.56%	203,000 $21.8 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $6.94 Million - $7.7 Million	90,000	90,000 $7.7 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.